Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dedee F Murrell

Showing results (91-100 of 258) with videos related to

Pageof 26
Sort By:
International Journal of Dermatology|December 18, 2025
Immunomodulators and Antineoplastics Are Reported in Drug-Associated Epidermolysis Bullosa Acquisita Flares: A Retrospective Analysis of 58 Reported Cases Utilizing Multiple International Pharmacovigilance DatabasesGaurav N Pathak, Brandon Tan, Aalia Syed, et al.
Journal of the American Academy of Dermatology|September 8, 2020
Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic"Hadir Shakshouk, Maryam Daneshpazhooh, Dedee F Murrell, et al.
International Journal of Women'S Dermatology|May 12, 2017
Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosaMinhee Kim, Swaranjali Jain, Adam G Harris, et al.
The Journal of Investigative Dermatology|August 17, 2011
The yin and the yang of keratin amino acid substitutions and epidermolysis bullosa simplexDedee F Murrell, Niken Trisnowati, Spiros Miyakis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 31, 2015
Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatmentJeremy C K Tan, Dedee F Murrell, Mark I Hersch
Journal of Drugs in Dermatology : JDD|October 14, 2015
Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept StudyDedee F Murrell, Kurt Gebauer, Lynda Spelman, et al.
JAAD International|September 12, 2022
Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic reviewFaith A P Zeng, Anna Wilson, Tabrez Sheriff, et al.
Frontiers in Medicine|August 26, 2022
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyondHamidreza Mahmoudi, Aikaterini Patsatsi, Dedee F Murrell, et al.
JAAD International|April 27, 2022
Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemicTimothy L Cowan, Genevieve Ho, Benjamin S Daniel, et al.
Frontiers in Medicine|September 11, 2023
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume IIAikaterini Patsatsi, Maryam Daneshpazhooh, Soheil Tavakolpour, et al.
Pageof 26

Showing results (91-100 of 258) with videos related to

Sort By:
Pageof 26
International Journal of Dermatology|December 18, 2025
Immunomodulators and Antineoplastics Are Reported in Drug-Associated Epidermolysis Bullosa Acquisita Flares: A Retrospective Analysis of 58 Reported Cases Utilizing Multiple International Pharmacovigilance DatabasesGaurav N Pathak, Brandon Tan, Aalia Syed, et al.
Journal of the American Academy of Dermatology|September 8, 2020
Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic"Hadir Shakshouk, Maryam Daneshpazhooh, Dedee F Murrell, et al.
International Journal of Women'S Dermatology|May 12, 2017
Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosaMinhee Kim, Swaranjali Jain, Adam G Harris, et al.
The Journal of Investigative Dermatology|August 17, 2011
The yin and the yang of keratin amino acid substitutions and epidermolysis bullosa simplexDedee F Murrell, Niken Trisnowati, Spiros Miyakis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 31, 2015
Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatmentJeremy C K Tan, Dedee F Murrell, Mark I Hersch
Journal of Drugs in Dermatology : JDD|October 14, 2015
Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept StudyDedee F Murrell, Kurt Gebauer, Lynda Spelman, et al.
JAAD International|September 12, 2022
Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic reviewFaith A P Zeng, Anna Wilson, Tabrez Sheriff, et al.
Frontiers in Medicine|August 26, 2022
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyondHamidreza Mahmoudi, Aikaterini Patsatsi, Dedee F Murrell, et al.
JAAD International|April 27, 2022
Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemicTimothy L Cowan, Genevieve Ho, Benjamin S Daniel, et al.
Frontiers in Medicine|September 11, 2023
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume IIAikaterini Patsatsi, Maryam Daneshpazhooh, Soheil Tavakolpour, et al.
Pageof 26